Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study of …

SA Taghavi, A Jafari, A Eshraghian - Digestive diseases and sciences, 2009 - Springer
This study compared a new regimen (group A: doxycycline, co-amoxiclav, omeprazole) and
two routinely prescribed regimens (group B: amoxicillin, omeprazole, furazolidone, bismuth; …
被引用次数：36 相关文章

Efficacy of a new therapeutic regimen versus two routinely prescribed treatments for eradication of Helicobacter pylori: a randomized, double-blind study of …

SA Taghavi, A Jafari, A Eshraghian - 2009 - pubmed.ncbi.nlm.nih.gov
This study compared a new regimen (group A: doxycycline, co-amoxiclav, omeprazole) and
two routinely prescribed regimens (group B: amoxicillin, omeprazole, furazolidone, bismuth; …
[PDF] researchgate.net

[PDF][PDF] Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study …

SA Taghavi, A Jafari, A Eshraghian - Dig Dis Sci, 2009 - researchgate.net
This study compared a new regimen (group A: doxycycline, co-amoxiclav, omeprazole) and
two routinely prescribed regimens (group B: amoxicillin, omeprazole, furazolidone, bismuth; …

[引用][C] Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study …

SA TAGHAVI, A JAFARI… - Digestive diseases and …, 2009 - pascal-francis.inist.fr
Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for
Eradication of Helicobacter Pylori : A Randomized, Double-Blind Study of Doxycycline, Co-Amoxiclav …

Efficacy of a new therapeutic regimen versus two routinely prescribed treatments for eradication of Helicobacter pylori: a randomized, double-blind study of …

SA Taghavi, A Jafari, A Eshraghian - Digestive Diseases and …, 2008 - europepmc.org
This study compared a new regimen (group A: doxycycline, co-amoxiclav, omeprazole) and
two routinely prescribed regimens (group B: amoxicillin, omeprazole, furazolidone, bismuth; …

Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study of …

SA Taghavi, A Jafari… - Digestive Diseases and …, 2009 - search.proquest.com
This study compared a new regimen (group A: doxycycline, co-amoxiclav, omeprazole) and
two routinely prescribed regimens (group B: amoxicillin, omeprazole, furazolidone, bismuth; …

Efficacy of a new therapeutic regimen versus two routinely prescribed treatments for eradication of Helicobacter pylori: a randomized, double-blind study of …

SA Taghavi, A Jafari, A Eshraghian - Digestive Diseases and …, 2009 - cabdirect.org
This study compared a new regimen (group A: doxycycline, co-amoxiclav, omeprazole) and
two routinely prescribed regimens (group B: amoxicillin, omeprazole, furazolidone, bismuth; …

Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study of …

SA Taghavi, A Jafari, A Eshraghian - Digestive Diseases and Sciences, 2009 - infona.pl
This study compared a new regimen (group A: doxycycline, co-amoxiclav, omeprazole) and
two routinely prescribed regimens (group B: amoxicillin, omeprazole, furazolidone, bismuth; …

[引用][C] Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind …

SA Taghavi, A Jafari, A Eshraghian - Digestive Diseases and Sciences, 2009 - Springer

[引用][C] Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study …

SA TAGHAVI, A JAFARI, A ESHRAGHIAN - Digestive diseases and …, 2009 - Springer